BNP Paribas Asset Management
SANA icon

BNP Paribas Asset Management’s Sana Biotechnology SANA Stock Holding History

BNP Paribas Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
3,140
+178
+6% +$573 ﹤0.01% 2200
2026
Q1 		$8.53K Buy
2,962
+681
+30% +$2.68K ﹤0.01% 2243
2025
Q4 		$9K Buy
2,281
+695
+44% +$3.11K ﹤0.01% 2184
2025
Q3 		$6K Buy
+1,586
New +$5.73K ﹤0.01% 1791

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

BNP Paribas Asset Management's SANA Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Sana Biotechnology (SANA) stake by 6% in Q2 2026, buying an estimated $573 and bringing the position to 3,140 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

BNP Paribas Asset Management first reported a position in SANA in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • BNP Paribas Asset Management held 3,140 shares of Sana Biotechnology worth $11K as of Q2 2026.
  • BNP Paribas Asset Management bought 178 Sana Biotechnology shares in Q2 2026, an estimated $573.
  • Sana Biotechnology made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2200 holding.
  • BNP Paribas Asset Management first reported a position in Sana Biotechnology in Q3 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.